Comparison of Long-term Outcomes Between Alemtuzumab and Rabbit Anti-thymocyte Globulin for Acute Kidney Allograft Rejection

Research output: Contribution to journalMeeting AbstractPopular

Original languageEnglish
Pages (from-to)132-132
Number of pages1
JournalTransplant International
Volume32
Publication statusPublished - Oct 2019

Cite this